Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus

• Published in: PloS one Vol. 15; no. 7; p. e0236453
• Main Authors: Salama, Iman I., Sami, Samia M., Abdellatif, Ghada A., Mohsen, Amira, Rasmy, Hanaa, Kamel, Solaf Ahmed, Ibrahim, Mona Hamed, Mostafa, Mona, Fouad, Walaa A., Raslan, Hala M.
• Format: Journal Article
• Language: English
• Published: San Francisco Public Library of Science 29.07.2020; Public Library of Science (PLoS)
• Subjects: Alzheimer's disease; Biology and Life Sciences; Biomarkers; Blood plasma; Blood pressure; Cognition; Cognition & reasoning; Cognitive ability; Cognitive disorders; Complications and side effects; Dementia; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diagnosis; Diagnostic systems; Disease; Drugs; Education; Gender; Gene expression; Genetic aspects; Health aspects; Hemoglobin; Hypertension; Identification methods; Impairment; Internal medicine; Lipids; Medicine; Medicine and Health Sciences; MicroRNA; MicroRNAs; miRNA; Pathology; Plasma; Quality of life; Regression analysis; Risk analysis; Risk factors; Sensitivity; Type 2 diabetes; Egypt; Cairo Egypt; United States > US; Germany

To assess the potential value of some miRNAs as diagnostic biomarkers for mild cognitive impairment (MCI) among patients with type2 diabetes mellitus (T2DM) and to identify other risk factors for MCI among them. This study enrolled 163 adults with T2DM using face to face interview. Cognitive functio...